Skip to main content Skip to journal navigation menu Skip to site footer
contact@ukscip.com
Article

Research Progress in the Treatment of Olfactory Dysfunction

Kai Luo ORCID ,  Jianjun Wang ORCID ,  Meng Wang ORCID ,  Jianhui Li ORCID
    Received: 19 November 2025; Revised: 17 April 2026; Accepted: 14 July 2026; Published: 22 July 2026

    Abstract

    Olfaction is one of the primitive sensory functions in humans, and olfactory dysfunction often leads to a decline in patients' quality of life. However, clinical research on the treatment of olfactory dysfunction still faces certain challenges. This article reviews the global research progress in the treatment of olfactory dysfunction in recent years. The main approaches include pharmacotherapy, such as corticosteroids and biologics; olfactory training; surgical treatment; and several novel therapies, including intranasal platelet-rich plasma injection, electrical stimulation of the olfactory system, and olfactory mucosa transplantation. Among the various administration routes, oral, ultrasonic nebulized inhalation, and nasal irrigation therapies have demonstrated superior efficacy compared to intranasal corticosteroids. The researchers compared the efficacy and safety of eight monoclonal antibodies in the treatment of chronic rhinosinusitis with nasal polyps. In terms of improving the olfactory function: Dupilumab ranks first. Olfactory training is applicable for the treatment of post-infectious, post-traumatic, neurodegenerative, and idiopathic olfactory disorders. Compared with traditional training, the novel nasal plug-based olfactory training is more convenient, discreet, and diversified in scent selection, effectively reducing olfactory fatigue and significantly improving patient compliance and therapeutic outcomes. Although its short-term advantages have been demonstrated, further studies are required to validate its long-term efficacy and generalizability. Surgery is a double-edged sword: it can enhance olfactory function, but it may also lead to iatrogenic olfactory impairment. Currently, its main application is still in conductive olfactory disorders, especially for olfactory improvement in individuals with chronic rhinosinusitis accompanied by nasal polyps.

    Keywords

    References

    1. 1. Boesveldt, S.; Parma, V. The importance of the olfactory system in human well-being through nutrition and social behavior. Cell Tissue Res. 2021, 383, 559–567.
    2. 2. Oleszkiewicz, A.; Croy, I.; Hummel, T. The impact of olfactory loss on quality of life: A 2025 review. Chem. Senses. 2025, 50, bjaf023.
    3. 3. Tong, J.Y.; Wong, A.; Zhu, D.; et al. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: A systematic review and meta-analysis. Otolaryngol. Head Neck Surg. 2020, 163, 3–11.
    4. 4. Boscutti, A.; Delvecchio, G.; Pigoni, A.; et al. Olfactory and gustatory dysfunctions in SARS-CoV-2 infection: A systematic review. Brain Sci. 2021, 15, 100268.
    5. 5. Seo, B.S.; Lee, H.J.; Mo, J.H.; et al. Treatment of postviral olfactory loss with glucocorticoids, Ginkgo biloba, and mometasone nasal spray. Arch. Otolaryngol. Head Neck Surg. 2009, 135, 1000–1004.
    6. 6. Jiang, R.S.; Twu, C.W.; Liang, K.L. Medical treatment of traumatic anosmia. Otolaryngol. Head Neck Surg. 2015, 152, 954–958.
    7. 7. Ahmad, K.; Mohamad, H.; Mohammed, S.; et al. Biological treatments and surgical interventions for chronic rhinosinusitis with nasal polyps: A systematic review of clinical outcomes. ENT Updates 2025, 2, 23–36.
    8. 8. Seiden, A.M.; Duncan, H.J. The diagnosis of a conductive olfactory loss. Laryngoscope 2001, 111, 9–14.
    9. 9. Blomqvist, E.H.; Lundblad, L.; Bergstedt, H.; et al. Placebo-controlled, randomized, double-blind study evaluating the efficacy of fluticasone propionate nasal spray for the treatment of patients with hyposmia/anosmia. Acta Otolaryngol. 2003, 123, 862–868.
    10. 10. Reychler, G.; Colbrant, C.; Huart, C.; et al. Effect of three-drug delivery modalities on olfactory function in chronic sinusitis. Laryngoscope 2015, 125, 549–555.
    11. 11. Harvey, R.J.; Goddard, J.C.; Wise, S.K.; et al. Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation. Otolaryngol. Head Neck Surg. 2008, 139, 137–142.
    12. 12. Calvo-Henriquez, C.; Viera-Artiles, J.; Rodriguez-Iglesias, M.; et al. The role of corticosteroid nasal irrigations in the management of chronic rhinosinusitis: A state-of-the-art systematic review. J. Clin. Med. 2023, 12, 3605.
    13. 13. Jiramongkolchai, P.; Patel, S.; Schneider, J.S. Use of off-label nasal steroid irrigations in long-term management of chronic rhinosinusitis. Ear Nose Throat J. 2021, 100, 329–334.
    14. 14. Nguyen, T.P.; Patel, Z.M. Budesonide irrigation with olfactory training improves outcomes compared with olfactory training alone in patients with olfactory loss. Int. Forum Allergy Rhinol. 2018, 8, 977–981.
    15. 15. Barroso, B.; Valverde-Monge, I.; Alobid, I.; et al. Improvement in olfaction in patients with CRSwNP and severe asthma taking anti-IgE and anti-IL-5 biologics: A real-life study. J. Investig. Allergol. Clin. Immunol. 2022, 33, 37–44.
    16. 16. Bachert, C.; Sousa, A.R.; Lund, V.J.; et al. Reduced need for surgery in severe nasal polyposis with mepolizumab: Randomized trial. J. Allergy Clin. Immunol. 2017, 140, 1024–1031.e14.
    17. 17. Oykhman, P.; Paramo, F.A.; Bousquet, J.; et al. Comparative efficacy and safety of monoclonal antibodies and aspirin desensitization for chronic rhinosinusitis with nasal polyposis: A systematic review and network meta-analysis. J. Allergy Clin. Immunol. 2021, 149, 1286–1295.
    18. 18. Yeh, C.F.; Lan, M.Y.; Lin, C.C.; et al. Dual blockade of IL-4 and IL-13 with dupilumab ameliorates sensorineural olfactory dysfunction in mice with eosinophilic sinonasal inflammation. Rhinology 2024, 63, 32–42.
    19. 19. Patel, D.; Morris, J.S.; Acharya, V.; et al. Olfactory outcomes following biological therapy in chronic rhinosinusitis: A systematic review and meta-analysis. Rhinology 2025, 63, 642–654.
    20. 20. Mullol, J.; Han, J.K.; Laidlaw, T.M.; et al. Early and sustained improvements in sense of smell with tezepelumab in treatment patients with chronic rhinosinusitis with nasal polyps (WAYPOINT). Int. Forum Allergy Rhinol. 2026, 16, 484–494.
    21. 21. Lipworth, B.J.; Han, J.K.; Desrosiers, M.; et al. Tezepelumab in Adults with Severe Chronic Rhinosinusitis with Nasal Polyps. N. Engl. J. Med. 2025, 392, 1178–1188.
    22. 22. Wang, X.; Ren, P.; He, H.; et al. Targeted biologics for chronic rhinosinusitis with nasal polyps: Efficacy and safety comparison of eight monoclonal antibodies via network meta-analysis. Rhinology 2026, 64, 290–300.
    23. 23. Aiba, T.; Sugiura, M.; Mori, J.; et al. Effect of zinc sulfate on sensorineural olfactory disorder. Acta Otolaryngol. Suppl. 1999, 538, 202–204.
    24. 24. Hummel, T.; Whitcroft, K.L.; Rueter, G.; et al. Intranasal vitamin A is beneficial in post-infectious olfactory loss. Eur. Arch. Otorhinolaryngol. 2017, 274, 2819–2825.
    25. 25. Abolfazl, T.; Maryam, N.; Nematollah, J.J.; et al. Therapeutic effects of olfactory training and systemic vitamin A in patients with COVID-19-related olfactory dysfunction: A double-blinded randomized controlled clinical trial. Braz. J. Otorhinolaryngol. 2024, 90, 101451.
    26. 26. Sienkiewicz-Oleszkiewicz, B.; Oleszkiewicz, A.; Bock, M.A.; et al. Intranasal insulin's effects on the sense of smell. Rhinology 2023, 61, 404–411.
    27. 27. Dibildox, D.; Loyola-Nieto, P.; Brenner-Muslera, E.; et al. Intranasal insulin for COVID-19-related smell loss. Eur. Arch. Otorhinolaryngol. 2023, 281, 201–205.
    28. 28. Pekala, K.; Chandra, R.K.; Turner, J.H. Efficacy of olfactory training in patients with olfactory loss: A systematic review and meta-analysis. Int. Forum Allergy Rhinol. 2016, 6, 299–307.
    29. 29. Brann, J.H.; Firestein, S.J. A lifetime of neurogenesis in the olfactory system. Front. Neurosci. 2014, 8, 182.
    30. 30. Wang, L.; Chen, L.; Jacob, T. Evidence for peripheral plasticity in human odour response. J. Physiol. 2004, 554, 236–244.
    31. 31. Negoias, S.; Pietsch, K.; Hummel, T. Changes in olfactory bulb volume following lateralized olfactory training. Brain Imaging Behav. 2017, 11, 998–1005.
    32. 32. Chen, C.H.; Shih, C.F.; Hummel, T.; et al. Multidimensional benefits of olfactory training for chronic COVID-19-related olfactory dysfunction: A systematic review and meta-analysis. Rhinology 2025, 63, 431–440.
    33. 33. Hummel, T.; Rissom, K.; Reden, J.; et al. Effects of olfactory training in patients with olfactory loss. Laryngoscope 2009, 119, 496–499.
    34. 34. Konstantinidis, I.; Tsakiropoulou, E.; Bekiaridou, P.; et al. Use of olfactory training in posttraumatic and postinfectious olfactory dysfunction. Laryngoscope 2013, 123, E85–90.
    35. 35. Power Guerra, N.; Kruschwitz, E.; Krautwurst, D.; et al. Four odorants for olfactory training are enough: A pilot study. Eur. Arch. Otorhinolaryngol. 2024, 281, 6445–6458.
    36. 36. Winter, A.L.; Henecke, S.; Thunell, E.; et al. Olfactory training using nasal inserts is more effective due to increased adherence. Rhinology 2025, 63, 477–485.
    37. 37. Haxel, B.R. Recovery of olfaction after sinus surgery for chronic rhinosinusitis: A review. Laryngoscope 2019, 129, 1053–1059.
    38. 38. Kohli, P.; Naik, A.N.; Farhood, Z.; et al. Olfactory outcomes after endoscopic sinus surgery for chronic rhinosinusitis: A meta-analysis. Otolaryngol. Head Neck Surg. 2016, 155, 936–948.
    39. 39. Hernandez, A.K.; Wendler, O.; Mayr, S.; et al. Predictors of olfactory improvement after endoscopic sinus surgery in chronic rhinosinusitis with nasal polyps. J. Laryngol. Otol. 2022, 137, 524–531.
    40. 40. Bardaranfar, M.H.; Ranjbar, Z.; Dadgarnia, M.H.; et al. The effect of an absorbable gelatin dressing impregnated with triamcinolone within the olfactory cleft on polypoid rhinosinusitis smell disorders. Am. J. Rhinol. Allergy 2014, 28, 172–175.
    41. 41. Jiang, R.S.; Su, M.C.; Liang, K.L.; et al. Preoperative prognostic factors for olfactory change after functional endoscopic sinus surgery. Am. J. Rhinol. Allergy 2009, 23, 64–70.
    42. 42. Wu, Y.; Xue, Y.; Zheng, M.; et al. The use of fascia lata can minimize olfactory damage in endoscopic endonasal skull base surgery. Rhinology 2025, 63, 463–469.
    43. 43. Lee, S.H.; Lim, H.H.; Lee, H.M.; et al. Olfactory mucosal findings in patients with persistent anosmia after endoscopic sinus surgery. Ann. Otol. Rhinol. Laryngol. 2000, 109, 720–725.
    44. 44. Yan, C.H.; Jang, S.S.; Lin, H.F.C.; et al. Use of platelet-rich plasma for COVID-19-related olfactory loss: A randomized controlled trial. Int. Forum Allergy Rhinol. 2022, 13, 989–997.
    45. 45. Jerome, R.; Lechien, S.; Saussez, S. Effectiveness of multiple platelet-rich plasma injections for olfactory dysfunction. J. Otolaryngol. Head Neck Surg. 2026, 55, 19160216251410582.
    46. 46. Lechien, J.S. Platelet-rich plasma for posttraumatic olfactory dysfunction: Preliminary report of 33 patients. Otolaryngol. Head Neck Surg. 2025, 173, 1297–1301.
    47. 47. Ali, B.; Jafar, G.; Almeida, F.; et al. Efficacy of platelet rich plasma versus placebo for improvement in olfactory function in adults with olfactory dysfunction: A systematic review and meta-analysis. Laryngoscope Investig. Otolaryngol. 2025, 10, e70317.
    48. 48. Gunder, N.; Dörig, P.; Witt, M.; et al. Future therapeutic strategies for olfactory disorders: electrical stimulation, stem cell therapy, and transplantation of olfactory epithelium—An overview. HNO 2023, 71, 35–43.
    49. 49. Whitcroft, K.L.; Hernandez, A.P.; Andrews, P.; et al. Olfactory implants: International opinion paper on emerging technologies and clinical applications. Rhinology 2025, 63, 1–37.
    50. 50. Díaz, D.; Lepousez, G.; Gheusi, G.; et al. Bone marrow cell transplantation restores olfaction in the degenerated olfactory bulb. J. Neurosci. 2012, 32, 9053–9058.
    51. 51. Ochi, N.; Doi, K.; Uranagase, M.; et al. Bone marrow stem cell transplantation to olfactory epithelium. Ann. Otol. Rhinol. Laryngol. 2010, 119, 535–540.
    52. 52. Kurtenbach, S.; Goss, G.M.; Goncalves, S.; et al. Cell-based therapy restores olfactory function in an inducible model of hyposmia. Stem Cell Rep. 2019, 12, 1354–1365.
    53. 53. Yagi, S.; Costanzo, R.M. Grafting the olfactory epithelium to the olfactory bulb. Am. J. Rhinol. Allergy 2009, 23, 239–243.
    54. 54. Ikeda, K.; Ito, S.; Hibiya, R.; et al. Postoperative management of eosinophilic chronic rhinosinusitis with nasal polyps: Impact of high-dose corticosteroid nasal spray. Int. Arch. Otorhinolaryngol. 2019, 23, 101–103.
    55. 55. Kanan, M.; Alruwili, W.; Alrasheedi, L.; et al. Efficacy and safety of corticosteroid treatments in chronic rhinosinusitis management: A systematic review. ENT Updates 2024, 14, 126–140.
    56. 56. Rachitskaya, A.V.; Yuan, A. Argus II retinal prosthesis system: an update. Ophthalmic Genet. 2016, 37, 260–266.
    ×